Immune microenvironment heterogeneity characterizes biologically distinct KRAS(mut)/SPOP(mut) and KRAS(mut)/PIK3CA(mut) mesonephric-like adenocarcinoma subtypes revealed by integrated whole-exome and transcriptomic profiling

通过整合全外显子组和转录组分析揭示,免疫微环境异质性是生物学上不同的KRAS(mut)/SPOP(mut)和KRAS(mut)/PIK3CA(mut)中肾样腺癌亚型的特征。

阅读:1

Abstract

OBJECTIVE: This study aims to uncover the molecular biology and immune microenvironment of gynecological mesonephric-like adenocarcinoma (MLA). METHODS: To determine the comprehensive characteristics of MLA, 17 patients with MLA were retrospectively enrolled in this study. Whole-exome sequencing and mRNA sequencing were performed to explore the molecular features. The biological differences between MLAs and epithelial-initiated gynecologic tumors reported in The Cancer Genome Atlas database were also analyzed. RESULTS: KRAS mutations (82.4%) were considered the driving mechanism and were co-mutated with PIK3CA (47.1%) and SPOP (23.5%), but their functions were mutually exclusive. In addition, pathways and genes associated with kidney development were upregulated in MLA patients. Compared with adjacent tissues and common gynecological tumors in The Cancer Genome Atlas, Th2 signature and resting mast cells account for the majority in MLAs, rendering an immunosuppressive TME. Particularly, the expression levels of IFNG, IFN6, and IFN1 KRAS_SPOP group, significantly lower than the rates found in KRAS_PIK3CA group. KRAS_SPOP mutant MLAs, exhibited reduced immune infiltration in their tumor microenvironment. CONCLUSION: This is the first study to demonstrate the comprehensive molecular characteristics of MLA and detect biologically distinct subtypes of KRAS (mut)/SPOP (mut) and KRAS (mut)/PIK3CA (mut) MLAs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。